N
STRO icon

Nuveen’s Sutro Biopharma STRO Stock Holding History

Nuveen’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,090
Closed -$189K – 3406
2025
Q1 		$189K Sell
29,090
-103,288
-78% -$1.63M ﹤0.01% 3140
2024
Q4 		$2.44M Buy
132,378
+12,416
+10% +$379K ﹤0.01% 2293
2024
Q3 		$4.15M Buy
119,962
+29,418
+32% +$1.15M ﹤0.01% 2075
2024
Q2 		$2.65M Buy
90,544
+56,781
+168% +$2.25M ﹤0.01% 2247
2024
Q1 		$1.91M Buy
33,763
+12,190
+57% +$538K ﹤0.01% 2426
2023
Q4 		$925K Buy
21,573
+358
+2% +$11.4K ﹤0.01% 2764
2023
Q3 		$736K Sell
21,215
-147
-0.7% -$6.4K ﹤0.01% 2700
2023
Q2 		$993K Sell
21,362
-2,484
-10% -$124K ﹤0.01% 2663
2023
Q1 		$1.1M Buy
23,846
+3,033
+15% +$192K ﹤0.01% 2577
2022
Q4 		$1.68M Sell
20,813
-2,247
-10% -$156K ﹤0.01% 2470
2022
Q3 		$1.28M Sell
23,060
-87
-0.4% -$5.15K ﹤0.01% 2635
2022
Q2 		$1.21M Buy
23,147
+4,534
+24% +$253K ﹤0.01% 2701
2022
Q1 		$1.48M Buy
18,613
+393
+2% +$37.4K ﹤0.01% 2651
2021
Q4 		$2.71M Sell
18,220
-17,606
-49% -$3.15M ﹤0.01% 2413
2021
Q3 		$6.77M Sell
35,826
-4,794
-12% -$912K ﹤0.01% 2054
2021
Q2 		$7.55M Buy
40,620
+2,097
+5% +$410K ﹤0.01% 2026
2021
Q1 		$8.77M Buy
38,523
+12,091
+46% +$2.87M ﹤0.01% 1874
2020
Q4 		$5.74M Buy
26,432
+15,488
+142% +$2.56M ﹤0.01% 1997
2020
Q3 		$1.1M Buy
10,944
+5,870
+116% +$555K ﹤0.01% 2644
2020
Q2 		$393K Buy
5,074
+1,130
+29% +$108K ﹤0.01% 2981
2020
Q1 		$403K Buy
3,944
+1,220
+45% +$128K ﹤0.01% 2846
2019
Q4 		$300K Sell
2,724
-99
-4% -$10.2K ﹤0.01% 3012
2019
Q3 		$257K Buy
2,823
+1,227
+77% +$124K ﹤0.01% 3079
2019
Q2 		$182K Buy
+1,596
New +$176K ﹤0.01% 3188

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Nuveen's STRO Position: Q2 2025 in Review

Nuveen sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 29,090 shares — an estimated $189K sold.

Nuveen first reported a position in STRO in Q2 2019 and held it in 24 quarters. The position peaked at $8.77M in Q1 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Nuveen reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 29,090 Sutro Biopharma shares in Q2 2025, an estimated $189K.
  • Nuveen first reported a position in Sutro Biopharma in Q2 2019 and held it in 24 quarters.
  • Nuveen's Sutro Biopharma position peaked at $8.77M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.